Clinical Trials Browser

Not yet recruiting × OTHER_GOV × Thoracic × Clear all

NCT07559786 2026-04-30

A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Phase 2 Not yet recruiting

SCLC, Limited Stage

NCT07523464 2026-04-13

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

Phase 1 Not yet recruiting

Locally-Advanced Non-Small Cell Lung Cancer

NCT07506889 2026-04-08

EXHALE-CO2

Not yet recruiting

Disease, Lung Neoplasms, Motor Activity

NCT06971848 2026-03-30

ETCABIO

Phase NA Not yet recruiting

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07442890 2026-03-02

A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron

Phase NA Not yet recruiting

Lung Neoplasms

NCT07400575 2026-02-10

NSCLC SCLC

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07280559 2025-12-12

Evaluation of AI-assisted LDCT Screening in Lung Cancer

Phase NA Not yet recruiting

Lung Neoplasms

NCT07108816 2025-08-07

A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)

Phase 2 Not yet recruiting

Resectable Stage II-IIIB NSCLC

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06971406 2025-05-14

FLAME-1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06854939 2025-03-03

MRDSEEKER

Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

NCT06793228 2025-01-27

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Phase 2 Not yet recruiting

SCLC, Extensive Stage

NCT06786208 2025-01-22

Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Phase 1 Not yet recruiting

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT06679712 2024-11-07

5ALA-TBPDT

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06614621 2024-09-26

A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06473870 2024-06-25

LUCIA

Not yet recruiting

Lung Neoplasms

NCT06454890 2024-06-12

Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06236997 2024-02-01

Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT05882630 2023-05-31

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma